Bharat Petroleum Corporation

Similar documents
Hindustan Petroleum Corporation

Discounting $45/bbl of realisation

Hindustan Petroleum Corporation

Jubilant FoodWorks NEUTRAL RESULTS REVIEW 4QFY17 30 MAY Highlights of the quarter

Healty cigarette-driven growth

BLS International Services

Crompton Greaves Consumer Electricals

Oil & Gas. 4QFY17E Results Preview. 13 Apr Deepak Kolhe

Jubilant FoodWorks BUY RESULTS REVIEW 1QFY18 18 JULY Highlights of the quarter

Mahanagar Gas BUY RESULTS REVIEW 1QFY19 01 AUG Highlights of the quarter. CMP (as on 1 Aug 2018) Rs 947 Target Price Rs 1,292

Crompton Greaves Consumer Electricals

Near-term pressure, but long-term outlook positive

Reliance Industries. Timing is everything BUY COMPANY UPDATE 1 OCT 2014

PI Industries BUY RESULTS REVIEW 1QFY19 07 AUG Highlights of the quarter

Navin Fluorine International

BHEL SELL RESULTS REVIEW 1QFY15 13 AUG CMP (as on 12 Aug 2014) Rs 224 Target Price Rs 188

Navin Fluorine International

Multi Commodity Exchange

J. Kumar Infraprojects

Intellect Design Arena

Ahluwalia Contracts. Cautious optimism BUY RESULTS REVIEW 4QFY17 31 MAY Highlights of the quarter

NRB Bearings. Strong Show BUY RESULTS REVIEW 4QFY18 23 MAY Highlights of the quarter

Marico Kaya BUY RESULTS REVIEW 4QFY15 29 APR 2015

Neuland Labs BUY RESULTS REVIEW 1QFY19 12 AUG 2018

Gulf Oil Lubricants BUY RESULTS REVIEW 1QFY19 09 AUG Key highlights

Vinati Organics BUY RESULTS REVIEW 2QFY19 29 OCT INDUSTRY CHEMICALS CMP (as on 29 Oct 2018) Rs 1,408 Target Price Rs 1,700

Coromandel International

Torrent Pharma BUY RESULTS REVIEW 1QFY18 01 AUG 2017

Central Depository Services

Agrochemicals. 3QFY18E Results Preview 09 JAN Basanth Patil

Central Depository Services

Strong volumes, offset by costs

Capital Goods. 3QFY18E Results Preview. 10 Jan Sujit Jain

Weak numbers in peak quarter

Sun Pharma BUY RESULTS REVIEW 1QFY19 16 AUG 2018

Ambuja Cement. Realisations-driven beat SELL RESULTS REVIEW 2QCY17 25 JUL Highlights of the quarter

Alkem Labs BUY RESULTS REVIEW 1QFY19 11 AUG story remains on-track. Maintain BUY with a revised TP of Rs 2,410 (24x FY20E EPS).

Hindustan Unilever BUY RESULTS REVIEW 4QFY17 18 MAY 2017

Central Depository Services

Kalpataru Power Transmission

Maruti Suzuki. A Trough Quarter BUY RESULTS REVIEW 3QFY19 25 JAN CMP(as on 25 Jan 2019) Rs 6,516 Target Price Rs 7,400

Carborundum Universal

Alkem Labs BUY RESULTS REVIEW 3QFY19 09 FEB CMP (as on 08 Feb 2019) Rs 1,904 Target Price Rs 2,340. Highlights of the quarter

Insecticides India BUY RESULTS REVIEW 4QFY17 30 MAY 2017

Real Estate. 3QFY19E Results Preview. 11 Jan Parikshit D Kandpal, CFA

Geared for version 3.0

Bajaj Auto BUY RESULTS REVIEW 1QFY18 21 JUL Highlights of the quarter

J. Kumar Infraprojects

Agriculture. 4QFY18E Results Preview 13 APR Madhukar Ladha

Exide Industries BUY RESULTS REVIEW 4QFY18 08 MAY Highlights of the quarter. CMP (as on 08 May 2018) Rs 268 Target Price Rs 298

Max Financial. Improving margins! BUY RESULTS REVIEW 4QFY18 30 MAY Highlights of the quarter

Dilip Buildcon. Strong comeback BUY RESULT REVIEW 1QFY19 16 AUG Highlights of the quarter. CMP (as on 16 Aug 2018) Rs 847 Target Price Rs 1,434

Music Broadcast. In-line but muted BUY RESULTS REVIEW 2QFY19 26 OCT Key highlights. CMP (as on 26 Oct 2018) Rs 328 Target Price Rs 387

Dishman Carbogen Amcis

Tata Steel. JV comes to fruition BUY COMPANY UPDATE 21 SEP Other key highlights. CMP (as on 20 Sep 17) Rs 688 Target Price Rs 818

Jubilant Life Sciences

Ambuja Cement. Weak numbers SELL RESULTS REVIEW 1QCY17 01 MAY 2017

ICICI Prudential Life

Pre-sales pickup key trigger

Hero MotoCorp BUY RESULTS REVIEW 2QFY19 16 OCT CMP (as on 16 Oct 2018) Rs 2,898 Target Price Rs 3,602. Highlights of the quarter

PSP Projects. Marginal miss BUY RESULTS REVIEW 1QFY19 10 AUG 2018

Dr. Reddy s Labs. Misery continues SELL RESULTS REVIEW 1QFY18 28 JUL 2017

Subros BUY RESULTS REVIEW 2QFY19 30 OCT CMP (as on 29 Oct 2018) Rs 268 TP Rs 435. Key highlights

Bajaj Auto NEUTRAL RESULTS REVIEW 2QFY16 23 OCT Key highlights. CMP (as on 23 Oct 2015) Rs 2,514 Target Price Rs 2,720

NIIT Technologies. NEUTRAL Higher capex weighing on FCF RESULTS REVIEW 2QFY15 16 OCT 2014

Bharti Infratel BUY RESULT REVIEW 3QFY19 25 JAN 2019

Brigade Enterprises. Stable performance BUY RESULTS REVIEW 2QFY19 14 NOV 2018

Suprajit Engineering. Synergies to accrue BUY COMPANY UPDATE 16 SEP 2016

Cyient. Good show, priced in NEUTRAL RESULTS REVIEW 4QFY17 21 APRIL Highlights of the quarter

Crompton Greaves Consumer Electricals

Sonata Software. On growth path BUY RESULTS REVIEW 1QFY18 16 AUG Highlights of the quarter

Radico Khaitan BUY RESULTS REVIEW 3QFY19 24 JAN 2019

Real Estate. 4QFY17E Results Preview. 13 Apr Parikshit D Kandpal

Chemicals and Fertilisers

Construction. 4QFY18E Results Preview 14 APR Parikshit D Kandpal

Thangamayil BUY RESULTS REVIEW 2QFY19 15 NOV 2018

ITC BUY RESULTS REVIEW 1QFY19 27 JUL 2018

Lupin BUY COMPANY UPDATE 12 SEP 2013

JBM Auto. Ready to take off BUY RESULTS REVIEW 1QFY19 07 AUG Key highlights

Hexaware Technologies

Emami NEUTRAL RESULTS REVIEW 4QFY15 14 MAY 2015

Weak quarter but well placed

Mphasis. Growth drivers intact BUY RESULTS REVIEW 3QFY19 25 JAN 2019

Bharat Forge. Cyclical headwinds persist but structural story intact BUY COMPANY UPDATE 9 DEC Key takeaways

Multi Commodity Exchange

IRB Infrastructure Developers

Reliance Industries NEUTRAL RESULTS REVIEW 4QFY17 25 APR Highlights of the quarter. CMP (as on 24 Apr 2017) Rs 1,414 Target Price Rs 1,375

Outperformance continues

ITD Cementation (India) Ltd.

Margin boost through non-core book

Coal India. Tough times BUY COMPANY UPDATE 22 AUG CMP (as on 21 Aug 17) Rs 238 Target Price Rs 300

V-Guard BUY RESULTS REVIEW 3QFY19 02 FEB 2019

Brigade Enterprises BUY RESULTS REVIEW 2QFY16 03 NOV Highlights of the quarter. CMP (as on 03 Nov 2015) Rs 162 Target Price Rs 210

FIRSTSOURCE SOLUTIONS LTD.

Growth + cash flows = BUY

Construction & Infra. 1QFY19E Results Preview 10 JUL Parikshit D Kandpal

Residential recovery awaited

Mindtree. Steady quarter, Upside capped NEUTRAL RESULTS REVIEW 4QFY19 18 APR INDUSTRY CMP (as on 16 Apr 2019) Rs 972 Target Price Rs 1,040

IRB Infrastructure Developers

All eyes on acquired assets

Transcription:

INDUSTRY OIL & GAS CMP (as on 30 May 2017) Rs 738 Target Price Rs 720 Nifty 9,625 Sensex 31,159 KEY STOCK DATA Bloomberg BPCL IN No. of Shares (mn) 1,446 MCap (Rs bn) / ($ mn) 1,067/16,510 6m avg traded value (Rs mn) 1,703 STOCK PERFORMANCE (%) 52 Week high / low Rs 770/450 3M 6M 12M Absolute (%) 12.2 17.4 51.3 Relative (%) 3.8 0.5 34.7 SHAREHOLDING PATTERN (%) Promoters 54.93 FIs & Local MFs 6.34 FPIs 22.13 Public & Others 16.60 Source : BSE Satish Mishra satish.mishra@hdfcsec.com +91-22-6171-7334 Deepak Kolhe deepak.kolhe@hdfcsec.com +91-22-6171-7316 Kochi is the next trigger BPCL reported an EBITDA of Rs 22.1bn in 4QFY17, led by a decline in GRM, lower sales volumes and higher employee cost. PAT came in at Rs 18.4bn. Results are not comparable, owing to inventory/forex impacts. The last three years have been excellent for OMCs. The fall in crude prices led to a complete change in the fortunes of the sector, driven by (1) Strong global GRMs (robust demand, lower product prices, delay in new refineries), (2) Petchem margins are above their 5-year avg, (3) Higher profits in marketing, owing to strong volumes/margins, (4) Healing of the B/S (low oil subsidy, interest cost fell 50-60% in the last 3 years) and (5) Inventory gains. These factors have led OMCs to report the highest-ever PAT in FY17. Fundamentals remain positive for BPCL, owing to its superior refining assets, rising capacity of Kochi refinery, and a possible upside in marketing margins. However, the stock has moved up by ~50% over the last 12 months, and we see no immediate trigger. There will also be further deferment in value unlocking of upstream assets in the prevailing RESULTS REVIEW 4QFY17 30 MAY 2017 Bharat Petroleum Corporation NEUTRAL scenario of weak gas prices. Our SOTP target is Rs 720 (5.5x FY19E EV/e for standalone refining, 6.5x EV/e for marketing, Rs 62/sh from upstream and Rs 82/sh from other investments). Maintain NEUTRAL. Highlights of the quarter Reported GRM was USD 6.0/bbl (-3/-11% YoY/QoQ). Crude throughput was 6.0 mmt (-5/+2% YoY/QoQ). Product inventory gains were Rs 4.0bn (vs loss of Rs 9.9bn in 4QFY16, and gain of Rs 6.7bn in 3QFY17). Forex loss was Rs 3.3bn vs. losses of Rs 2.0bn YoY and Rs 1.5bn QoQ. Clarity awaited on E&P assets: (1) Mozambique: FID is expected in 1QCY18 and (2) Brazil: Appraisal of assets is underway. Near-term outlook: GST has caused uncertainty in the oil sector. This overhang will continue, unless the government addresses these concerns. Apart from GST, we see no major concern for IOC till the crude price remains below USD 65/bbl. Inventory impact and provisions may shock quarterly results. Financial Summary (Standalone) (Rs bn) 4QFY17 4QFY16 YoY (%) 3QFY17 QoQ (%) FY16 FY17P FY18E FY19E Net Sales 570.4 435.5 31.0 535.4 6.5 1,884.0 2,022.1 2,127.0 2,224.8 EBITDA 22.1 33.7 (34.4) 33.2 (33.3) 110.2 108.3 128.0 147.6 PAT 18.4 21.2 (13.0) 22.7 (18.9) 70.4 80.4 76.6 88.3 Diluted EPS (Rs) 14.0 16.1 (13.0) 17.3 (18.9) 53.7 61.3 58.5 67.3 P/E (x) 13.7 12.0 12.6 11.0 EV / EBITDA (x) 9.6 10.6 8.8 7.7 RoE (%) 28.3 28.2 24.3 24.6 HDFC securities Institutional Research is also available on Bloomberg HSLB <GO> & Thomson Reuters

Higher employee cost is owing to higher provisioning for pay revision Quarterly results are not comparable, owing to inventory and forex impact Quarterly Financials Snapshot (Rs bn) 4QFY17 4QFY16 YoY (%) 3QFY17 QoQ (%) Net Sales 570.36 435.55 31.0 535.43 6.5 Material Expenses 164.39 115.83 41.9 174.41 (5.7) Trading 340.37 243.97 39.5 289.53 17.6 Employee Expenses 14.37 8.20 75.3 6.82 110.7 Other Operating Expenses 29.11 33.85 (14.0) 31.50 (7.6) EBITDA 22.12 33.70 (34.4) 33.16 (33.3) Depreciation 5.24 4.30 21.9 4.84 8.3 EBIT 16.88 29.40 (42.6) 28.33 (40.4) Other Income (Including EO Items) 6.62 4.43 49.4 5.51 20.2 Interest Cost 1.48 2.41 (38.7) 1.35 9.4 PBT 22.03 31.43 (29.9) 32.49 (32.2) Tax 3.62 10.27 (64.8) 9.77 (63.0) RPAT 18.42 21.16 (13.0) 22.72 (18.9) EO (Loss) / Profit (Net Of Tax) - - - APAT 18.42 21.16 (13.0) 22.72 (18.9) EPS 14.0 16.1 (13.0) 17.3 (18.9) Margin Analysis 4QFY17 4QFY16 YoY (bps) 3QFY17 QoQ (bps) Raw Material as % of Net Sales 28.8 26.6 223 32.6 (375) Trading as % of Net Sales 59.7 56.0 366 54.1 560 Employee Expenses as % of Net Sales 2.5 1.9 64 1.3 125 Other Operating Expenses as % of Net Sales 5.1 7.8 (267) 5.9 (78) EBITDA Margin (%) 3.9 7.7 (386) 6.2 (232) Net Profit Margin (%) 3.2 4.9 (163) 4.2 (101) Tax Rate (%) 16.4 32.7 (1,627) 30.1 (1,366) Key Quarterly Data Physical Performance 4QFY17 4QFY16 YoY (%) 3QFY17 QoQ (%) Total Refinery Throughput (mnt) 6.0 6.2 (3.2) 6.8 (11.2) Average Refinery GRM (US$/bbl) 6.0 6.3 (4.6) 5.9 1.9 Domestic Sales (mnt) 9.3 9.8 (5.3) 9.8 (5.1) Export Sales (mnt) 0.8 0.5 50.0 0.8 8.0 Net Under/(Over) Recovery (Rs bn) - (0.5) (100.0) - - Exchange Gain/(Loss) (Rs bn) 3.3 (2.0) (1.5) Inventory Gain/(Loss) (Rs bn) 4.0 (9.9) 6.7 (39.5) Debt (Rs bn) 232 160 45.0 163 42.3 Page 2

Kochi capacity will be expanded to 15.5 mtpa in FY18 from 9.5 currently Benefits of GRM expansion in Kochi will be visible in FY19 We expect diesel margins to increase 5% annually in FY17/18E Lower gross UR will lead to no net UR and lower debt Assumptions FY12 FY13 FY14 FY15 FY16 FY17P FY18E FY19E REFINING BUSINESS Throughput (mnt) 22.9 23.2 23.4 23.4 24.1 25.4 28.3 30.7 GRM (US$/bbl) 3.2 5.0 4.3 3.6 6.6 5.3 5.5 6.4 MARKETING BUSINESS Total Sales (mnt) 31.1 33.3 34.0 34.4 36.5 37.7 39.3 41.1 YoY Gr (%) 6.4 6.9 2.1 1.3 6.1 3.1 4.4 4.6 Diesel Volume (mn T) 16.3 18.0 18.3 18.4 19.4 19.8 20.3 20.8 Diesel Volume Gr (%) 13.2 10.3 11.3 0.3 5.4 2.0 2.5 2.5 Petrol Volume Gr (%) 6.1 7.0 8.4 11.1 12.4 6.7 9.0 9.0 Diesel Margin (Rs/l) 1.40 1.40 1.40 1.40 1.54 1.62 1.70 1.78 MACRO INR-US$ 47.9 54.5 60.5 61.2 65.5 66.5 66.0 66.0 Crude Price (US$/bbl) 114.5 110.0 107.8 90.5 47.6 50.0 55.0 55.0 Total Sector UR (Rs bn) 1,385 1,610 1,399 723 276 237 295 283 BPCL Gross UR (Rs bn) 326 390 345 161 58 50 62 60 BPCL Net UR (Rs bn) 0.1 2.5 5.1 4.9 - - - - Change in FY18 estimates factoring the commissioning of the delayed coker unit at Kochi in 2HFY18 Change In Estimates (Rs bn) FY18 Old FY18 New % Ch Net Sales 2,138.04 2,127.04 (0.5) EBIDTA 131.37 128.03 (2.5) APAT 78.95 76.65 (2.9) AEPS (Rs/sh) 60.2 58.5 (2.9) Source: HDFC sec Inst Research (Rs bn) FY19 New FY19 New % Ch Net Sales 2,223.85 2,224.80 0.0 EBIDTA 147.09 147.59 0.3 APAT 88.02 88.28 0.3 AEPS (Rs/sh) 67.1 67.3 0.3 Page 3

Consortium of BPCL, IOC and Oil India has purchased stake in Russian fields of Vankor (24% stake) and Taas Yuryakh (30% stake). Total consideration was USD 3.1bn. We are not yet factoring this transaction in our valuation and are awaiting further details Peer Valuations Mcap (Rs bn) CMP (Rs/sh) Valuation (Based on FY19E) Business EBITDA (Rs bn) Multiple Value (Rs bn) Value (Rs/sh)* Valuation basis Standalone Refining 60.39 5.5 332 253 EV/EBIDTA on FY19E Marketing 80.92 6.5 526 401 EV/EBIDTA on FY19E Pipelines 6.28 9.0 57 43 EV/EBIDTA on FY19E Standalone net Debt (160) (122) As on Mar-18E Standalone Equity Value 755 576 E & P Mozambique 0.80 128 98 20% discount to ONGC deal (10% @ $ 2.5bn) Brazil 13 10 Oil reserve of 200 mmboe @$5.0/bbl E&P EV 107 E&P Debt (59) (45) E&P Equity Value 62 Investments Traded investments 0.8 80 49 20% discount to CMP Numaligarh Refinery (NRL) 1.5 50 24 1.5x NRL's net-worth as of Mar-16P, BPCL's stake 61.65% Other non traded investments 1.0 13 10 1x BV Investments Equity Value 82 Value per share 720, * Valuation is based on 1.312 bn shares (net of treasury shares) Reco. TP (Rs/sh ) EPS (Rs/sh) P/E (x) P/BV (x) ROE (%) FY17E FY18E FY19E FY17E FY18E FY19E FY17E FY18E FY19E FY17E FY18E FY19E Reliance Industries 4,419 1,359 NEU 1,375 96.7 111.5 126.3 14.1 12.2 10.8 1.5 1.4 1.2 11.6 11.9 12.2 ONGC 2,293 179 BUY 228 14.2 15.3 16.8 12.6 11.7 10.6 1.4 1.4 1.3 11.7 12.0 12.4 Indian Oil Corp 1,988 420 BUY 470 40.3 40.4 43.1 10.4 10.4 9.7 2.0 1.8 1.6 20.3 18.2 17.5 BPCL 1,067 738 NEU 720 61.3 58.5 67.3 12.0 12.6 11.0 3.3 2.9 2.5 28.2 24.3 24.6 Gail India 686 405 BUY 440 22.5 28.9 30.0 18.0 14.0 13.5 1.8 1.7 1.5 10.4 12.3 11.9 HPCL 563 554 NEU 580 54.6 51.8 50.0 10.1 10.7 11.1 2.8 2.5 2.3 28.7 24.6 21.5 Petronet LNG 328 438 BUY 485 22.7 25.9 30.2 19.2 16.9 14.5 4.1 3.4 2.9 23.2 22.1 21.9 OIL India 252 315 NEU 370 26.0 25.8 25.8 12.1 12.2 12.2 1.1 1.1 1.0 9.2 8.8 8.5 Indraprastha Gas 148 1,060 BUY 1,230 40.8 45.3 50.6 26.0 23.4 20.9 5.1 4.4 3.8 21.0 20.0 19.3 Page 4

Standalone Income Statement (Rs bn) FY15 FY16 FY17P FY18E FY19E Net Revenues 2,380.87 1,884.05 2,022.11 2,127.04 2,224.80 Growth % (8.5) (20.9) 7.3 5.2 4.6 Raw Material 989.38 618.41 621.33 848.89 921.88 Trading 1,170.52 1,008.29 1,142.20 988.98 983.78 Employee Cost 20.86 27.58 34.29 37.04 40.00 Other Expenses 116.97 119.52 115.99 124.11 131.55 EBITDA 83.15 110.25 108.29 128.03 147.59 EBITDA growth % 2.6 32.6 (1.8) 18.2 15.3 EBITDA Margin % 3.5 5.9 5.4 6.0 6.6 Depreciation 25.16 18.45 18.91 24.92 27.65 EBIT 57.99 91.80 89.38 103.11 119.94 Other Income (Including EO Items) 22.00 17.76 26.01 15.64 15.94 Interest Cost 5.83 5.65 4.96 7.35 7.58 PBT 74.16 103.91 110.43 111.40 128.31 Taxes 23.31 33.35 30.03 34.75 40.02 RPAT 50.85 70.56 80.39 76.65 88.28 EO (Loss) / Profit (Net Of Tax) 3.48 0.13 - - - APAT 47.36 70.43 80.39 76.65 88.28 Growth % 16.7 48.7 14.1 (4.7) 15.2 EPS 36.1 53.7 61.3 58.5 67.3 Standalone Balance Sheet (Rs bn) FY15 FY16 FY17P FY18E FY19E SOURCES OF FUNDS Share Capital 7.23 6.56 13.11 13.11 13.11 Reserves 217.44 266.67 283.57 321.20 369.04 Total Shareholders Funds 224.67 273.23 296.68 334.31 382.15 Long-term Debt 117.37 135.67 137.76 137.76 150.76 Short-term Debt 13.61 22.90 94.93 94.93 94.93 Total Debt 130.98 158.57 232.70 232.70 245.70 Net Deferred Taxes 17.08 26.22 35.02 35.02 35.02 LT Provisions & Others 11.79 12.88 14.98 14.98 14.98 Total Liabilities 384.52 470.90 579.38 617.01 677.85 APPLICATION OF FUNDS Net Block 203.15 232.07 314.37 352.87 390.22 CWIP 81.74 128.78 118.36 133.36 148.36 Investments 73.02 76.32 92.42 92.42 92.42 LT Loans and Advances 35.69 17.64 35.70 35.70 35.70 Other Non-current Assets 0.83 16.73 16.47 16.47 16.47 Total Non-current Assets 394.43 471.55 577.32 630.81 683.16 Inventories 144.58 137.93 197.98 192.31 201.15 Debtors 25.61 21.89 47.58 46.62 48.76 Cash and Cash Equivalent 64.49 72.47 54.25 72.70 78.48 Loans And Advances 7.86 0.66 0.71 0.71 0.71 Other Current Assets 60.47 49.08 42.06 17.33 14.42 Total Current Assets 303.01 282.03 342.58 329.66 343.51 Creditors 124.67 84.31 113.60 116.55 121.91 Other Current Liabilities & Provns 188.26 198.37 226.92 226.92 226.92 Total Current Liabilities 312.93 282.67 340.51 343.47 348.82 Net Current assets (9.91) (0.65) 2.07 (13.80) (5.31) Total Assets 384.52 470.90 579.38 617.01 677.85 Page 5

Standalone Cash Flow (Rs bn) FY15 FY16 FY17P FY18E FY19E Reported PBT 74.16 103.91 110.43 111.40 128.31 Non-operating & EO Items (17.07) (8.07) (26.01) (15.64) (15.94) Interest Expenses 5.83 5.65 4.96 7.35 7.58 Depreciation 25.16 18.54 18.91 24.92 27.65 Working Capital Change 117.05 7.20 (20.93) 34.32 (2.72) Tax Paid (23.30) (24.90) (30.03) (34.75) (40.02) OPERATING CASH FLOW ( a ) 181.83 102.34 57.33 127.60 104.85 Capex (81.33) (90.71) (88.82) (80.00) (80.00) Free Cash Flow (FCF) 100.50 11.63 (31.49) 47.60 24.85 Investments (0.64) (3.30) (16.09) - - Non-operating Income 17.03 17.57 26.01 15.64 15.94 Others (14.15) (2.12) (0.00) - - INVESTING CASH FLOW ( b ) (79.09) (78.56) (78.91) (64.36) (64.06) Debt Issuance/(Repaid) (70.30) 20.53 74.12-13.00 Interest Expenses (5.83) (5.65) (4.96) (7.35) (7.58) FCFE 24.37 26.51 37.67 40.25 30.27 Share Capital Issuance - (0.67) 6.56 - - Dividend (14.25) (32.78) (52.71) (39.02) (40.44) Others (0.83) (1.54) (6.56) (0.00) - FINANCING CASH FLOW ( c ) (91.21) (20.12) 16.45 (46.37) (35.02) NET CASH FLOW (a+b+c) 11.53 3.66 (5.13) 16.87 5.78 EO Items, Others 4.84 3.50 0.90 - - Closing Cash & Equivalents 64.49 72.47 54.25 72.70 78.48 Standalone Key Ratios FY15 FY16 FY17P FY18E FY19E PROFITABILITY % EBITDA Margin 3.5 5.9 5.4 6.0 6.6 EBIT Margin 2.4 4.9 4.4 4.8 5.4 APAT Margin 2.0 3.7 4.0 3.6 4.0 RoE 22.6 28.3 28.2 24.3 24.6 Core RoCE 17.3 37.9 28.6 24.1 26.0 RoCE 12.9 18.1 16.6 14.1 14.9 EFFICIENCY Tax rate % 31.4 32.1 27.2 31.2 31.2 Asset Turnover (x) 6.0 4.6 4.0 3.7 3.6 Inventory (days) 22 27 36 33.0 33.0 Debtor (days) 4 4 9 8.0 8.0 Other Current Assets (days) 6 7 10 9.3 8.9 Payables (days) 19 16 21 20.0 20.0 Other Current Liab & Provns (days) 29 38 41 38.9 37.2 Cash conversion cycle (days) (16) (17) (7) (8.6) (7.3) Net Debt/EBITDA (x) 0.8 0.8 1.6 1.2 1.1 Net D/E 0.3 0.3 0.6 0.5 0.4 Interest Coverage 13.7 19.4 23.3 16.2 17.9 PER SHARE DATA (Rs) EPS 36.1 53.7 61.3 58.5 67.3 CEPS 55.3 67.8 75.7 77.5 88.4 DPS 12.4 17.1 33.5 24.8 25.7 BV 171.3 208.4 226.3 255.0 291.4 VALUATION P/E (x) 20.4 13.7 12.0 12.6 11.0 P/Cash EPS (x) 13.3 10.9 9.7 9.5 8.3 P/BV (x) 4.3 3.5 3.3 2.9 2.5 EV/EBITDA (x) 12.4 9.6 10.6 8.8 7.7 EV/Revenue (x) 0.4 0.6 0.6 0.5 0.5 OCF/EV (%) 17.6 9.7 5.0 11.3 9.2 FCFF /EV (%) 9.7 1.1 (2.7) 4.2 2.2 FCFE/M CAP (%) 2.5 2.7 3.9 4.2 3.1 Dividend Yield (%) 1.7 2.3 4.5 3.4 3.5 Page 6

RECOMMENDATION HISTORY BPCL 800 700 600 500 400 TP Date CMP Reco Target 30-May-16 506 BUY 570 22-Jul-16 576 BUY 650 2-Sep-16 587 BUY 650 7-Oct-16 664 NEU 645 15-Nov-16 644 NEU 680 10-Feb-17 727 NEU 730 30-May-17 738 NEU 720 300 May-16 Jun-16 Jul-16 Aug-16 Sep-16 Oct-16 Nov-16 Dec-16 Jan-17 Feb-17 Mar-17 Apr-17 May-17 Rating Definitions BUY : Where the stock is expected to deliver more than 10% returns over the next 12 month period NEUTRAL : Where the stock is expected to deliver (-)10% to 10% returns over the next 12 month period SELL : Where the stock is expected to deliver less than (-)10% returns over the next 12 month period Page 7

Disclosure: We, Satish Mishra, PGDM, & Deepak Kolhe, MBA, authors and the names subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect our views about the subject issuer(s) or securities. HSL has no material adverse disciplinary history as on the date of publication of this report. We also certify that no part of our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. Research Analyst or his/her relative or HDFC Securities Ltd. does not have any financial interest in the subject company. Also Research Analyst or his relative or HDFC Securities Ltd. or its Associate may have beneficial ownership of 1% or more in the subject company at the end of the month immediately preceding the date of publication of the Research Report. Further Research Analyst or his relative or HDFC Securities Ltd. or its associate does not have any material conflict of interest. Any holding in stock No HDFC Securities Limited (HSL) is a SEBI Registered Research Analyst having registration no. INH000002475. Disclaimer: This report has been prepared by HDFC Securities Ltd and is meant for sole use by the recipient and not for circulation. The information and opinions contained herein have been compiled or arrived at, based upon information obtained in good faith from sources believed to be reliable. Such information has not been independently verified and no guaranty, representation of warranty, express or implied, is made as to its accuracy, completeness or correctness. All such information and opinions are subject to change without notice. This document is for information purposes only. Descriptions of any company or companies or their securities mentioned herein are not intended to be complete and this document is not, and should not be construed as an offer or solicitation of an offer, to buy or sell any securities or other financial instruments. This report is not directed to, or intended for display, downloading, printing, reproducing or for distribution to or use by, any person or entity who is a citizen or resident or located in any locality, state, country or other jurisdiction where such distribution, publication, reproduction, availability or use would be contrary to law or regulation or what would subject HSL or its affiliates to any registration or licensing requirement within such jurisdiction. If this report is inadvertently send or has reached any individual in such country, especially, USA, the same may be ignored and brought to the attention of the sender. This document may not be reproduced, distributed or published for any purposes without prior written approval of HSL. Foreign currencies denominated securities, wherever mentioned, are subject to exchange rate fluctuations, which could have an adverse effect on their value or price, or the income derived from them. In addition, investors in securities such as ADRs, the values of which are influenced by foreign currencies effectively assume currency risk. It should not be considered to be taken as an offer to sell or a solicitation to buy any security. HSL may from time to time solicit from, or perform broking, or other services for, any company mentioned in this mail and/or its attachments. HSL and its affiliated company(ies), their directors and employees may; (a) from time to time, have a long or short position in, and buy or sell the securities of the company(ies) mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions. HSL, its directors, analysts or employees do not take any responsibility, financial or otherwise, of the losses or the damages sustained due to the investments made or any action taken on basis of this report, including but not restricted to, fluctuation in the prices of shares and bonds, changes in the currency rates, diminution in the NAVs, reduction in the dividend or income, etc. HSL and other group companies, its directors, associates, employees may have various positions in any of the stocks, securities and financial instruments dealt in the report, or may make sell or purchase or other deals in these securities from time to time or may deal in other securities of the companies / organizations described in this report. HSL or its associates might have managed or co-managed public offering of securities for the subject company or might have been mandated by the subject company for any other assignment in the past twelve months. HSL or its associates might have received any compensation from the companies mentioned in the report during the period preceding twelve months from t date of this report for services in respect of managing or co-managing public offerings, corporate finance, investment banking or merchant banking, brokerage services or other advisory service in a merger or specific transaction in the normal course of business. HSL or its analysts did not receive any compensation or other benefits from the companies mentioned in the report or third party in connection with preparation of the research report. Accordingly, neither HSL nor Research Analysts have any material conflict of interest at the time of publication of this report. Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. HSL may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report. Research entity has not been engaged in market making activity for the subject company. Research analyst has not served as an officer, director or employee of the subject company. We have not received any compensation/benefits from the subject company or third party in connection with the Research Report. HDFC securities Limited, I Think Techno Campus, Building - B, "Alpha", Office Floor 8, Near Kanjurmarg Station, Opp. Crompton Greaves, Kanjurmarg (East), Mumbai 400 042 Phone: (022) 3075 3400 Fax: (022) 2496 5066 Compliance Officer: Binkle R. Oza Email: complianceofficer@hdfcsec.com Phone: (022) 3045 3600 HDFC Securities Limited, SEBI Reg. No.: NSE-INB/F/E 231109431, BSE-INB/F 011109437, AMFI Reg. No. ARN: 13549, PFRDA Reg. No. POP: 04102015, IRDA Corporate Agent License No.: HDF 2806925/HDF C000222657, SEBI Research Analyst Reg. No.: INH000002475, CIN - U67120MH2000PLC152193 Mutual Funds Investments are subject to market risk. Please read the offer and scheme related documents carefully before investing. Page 8

HDFC securities Institutional Equities Unit No. 1602, 16th Floor, Tower A, Peninsula Business Park, Senapati Bapat Marg, Lower Parel, Mumbai - 400 013 Board : +91-22-6171 7330 www.hdfcsec.com Page 9